Therapeutic Effect of Modified Gexia Zhuyu Decoction for the Treatment of Precancerous Lesion of Chronic Atrophic Gastritis:An Observation of 28 Cases
Yuan Lixi
Abstract
Yuan Lixi
Abstract
Objective:To observe the therapeutic effect of Modified Gexia Zhuyu Decoction (MGZD) for the treatment of precancerous lesion of chronic atrophic gastritis.Methods:Forty-four qualified patients were randomized into 2 groups:the treatment group(n=28) received MGZD based on syndrome differentiation,and the control group(n=16) received Weifuchun.The therapeutic effect was evaluated after treatment Results:The total therapeutic effective rate was 85.7%in the treatment group,and 56.3%in the control group,the difference being significant between the two groups(P0.05).The total gastroscopic and histopathological effective rate was 82.1%in the treatment group and 50.0%in the control group,the difference being significant between the two groups(P0.05).Conclusion:MGZD shows certain effect on relieving clinical symptoms and gastric mucosal precancerous lesion in patients with precancerous lesion of chronic atrophic gastritis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the therapeutic effect of Modified Gexia Zhuyu Decoction (MGZD) for the treatment of precancerous lesion of chronic atrophic gastritis.Methods:Forty-four qualified patients were randomized into 2 groups:the treatment group(n=28) received MGZD based on syndrome differentiation,and the control group(n=16) received Weifuchun.The therapeutic effect was evaluated after treatment Results:The total therapeutic effective rate was 85.7%in the treatment group,and 56.3%in the control group,the difference being significant between the two groups(P0.05).The total gastroscopic and histopathological effective rate was 82.1%in the treatment group and 50.0%in the control group,the difference being significant between the two groups(P0.05).Conclusion:MGZD shows certain effect on relieving clinical symptoms and gastric mucosal precancerous lesion in patients with precancerous lesion of chronic atrophic gastritis.
Key concepts: Medicine, Decoction, Atrophic gastritis, Precancerous lesion, Therapeutic effect, Lesion, Gastroenterology, Internal medicine